Doctors for America Lunch & Learn – Racing to the Bottom: FDA’s Approval of Aducanumab
Join us for this Doctors for America program in which Dr. Madhav Thambisetty is a program participant. The program is about the FDA's controversial approval of the Alzheimer's drug, aducanumab (sold as Aduhelm by Biogen). In addition to Dr. Thambisetty, the program will include Caleb Alexander, MD and Holly Fernandez Lynch, JD, MBE. Drs. Alexander […]
